Comments
Loading...
Astria Therapeutics (ATXS) Forecast
NewsEarningsAstria Therapeutics (ATXS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Astria Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ATXS | Benzinga
Explore Astria Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATXS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Astria Therapeutics (ATXS) stock?
You can purchase shares of Astria Therapeutics (NASDAQ:ATXS) through any online brokerage.
Who are Astria Therapeutics (ATXS) competitors?
Other companies in Astria Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Anika Therapeutics (NASDAQ:ANIK), Abeona Therapeutics (NASDAQ:ABEO) and Design Therapeutics (NASDAQ:DSGN).
What is the forecast, or price target, for Astria Therapeutics (ATXS) stock?
Astria Therapeutics has a consensus price target of $25.50.
What is the current price for Astria Therapeutics (ATXS)?
The stock price for Astria Therapeutics (NASDAQ: ATXS) is $4.095 last updated April 21, 2025 at 12:07 PM EDT.
Does Astria Therapeutics (ATXS) pay a dividend?
There are no upcoming dividends for Astria Therapeutics.
When is Astria Therapeutics (NASDAQ:ATXS) reporting earnings?
Astria Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Astria Therapeutics (ATXS) going to split?
There is no upcoming split for Astria Therapeutics.
What sector and industry does Astria Therapeutics (ATXS) operate in?
Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
